Reasons for Conversion and Adverse Intraoperative Events in Robotically Enhanced Minimally Invasive Coronary Artery Revascularization.
Johan van der MerweFilip P CasselmanYvette VermeulenBernard StockmanIvan DegrieckFrank Van PraetPublished in: Innovations (Philadelphia, Pa.) (2020)
RE-MIDCAB provides an attractive surgical platform for primary- or hybrid coronary artery procedures. The progressive increase in patient risk profiles, strict quality control, and focus on clinical governance require awareness of reasons that potentially contribute RE-MIDCAB to sternotomy conversion to ensure safe and sustainable programs.
Keyphrases
- coronary artery
- quality control
- minimally invasive
- pulmonary artery
- multiple sclerosis
- case report
- public health
- percutaneous coronary intervention
- high throughput
- coronary artery bypass grafting
- patients undergoing
- aortic valve replacement
- coronary artery disease
- global health
- heart failure
- pulmonary hypertension
- left ventricular
- adverse drug
- atrial fibrillation
- ejection fraction